Eloxx Pharmaceuticals, Inc. (ELOX) Financials
ELOX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 63.4 million | 17.0 million |
| March 31, 2026 | 8.5 million | 16.1 million |
| Dec. 31, 2025 | 5.3 million | 17.2 million |
| March 31, 2025 | ? | ? |
ELOX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -4.8 million | 95000 |
| March 31, 2026 | -5.5 million | 46000 |
| Dec. 31, 2025 | ? | ? |
| March 31, 2025 | 1.2 million | 20000 |
ELOX Net Income
No data available :(
ELOX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 62.0 million | - | - |
| March 31, 2026 | 6.4 million | - | - |
| Dec. 31, 2025 | 4.8 million | - | - |
| March 31, 2025 | - | - | - |
ELOX Shares Outstanding
ELOX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 2.8 million | 1.6 million | - |
| March 31, 2026 | - | 1.7 million | 2.1 million | - |
| Dec. 31, 2025 | - | - | - | - |
| March 31, 2025 | - | 510000 | 712000 | - |
ELOX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| March 31, 2025 | - | - |
ELOX
Price: $13.03
52 week price:
Earnings Per Share: -8.88 USD
P/E Ratio: -0.10
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 67300
Market Capitalization: 53.3 million